RADIENT PHARMACEUTICALS CORPORATION

Company News Products Distribution Resources Investor Contact

 

Clinical Studies
Review Articles
Return Home
 
 
Review Articles

A collection of independent reports relevant to Radient Pharma's research in cancer diagnostics and treatment

  • An effective cancer vaccine modality: Lentiviral modification of
    dendritic cells expressing multiple cancer-specific antigens
    NIH Public Access Author Manuscript, April 24, 2006
  • Cancer Immunogene Therapy: A Review
    Journal of Biomedical Science, August 7, 2002